<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Referral</a></li><li><a href="#id2">Reason for Visit</a></li><li><a href="#id3">Encounter Details</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Last Filed Vital Signs</a></li><li><a href="#id6">Patient Instructions</a></li><li><a href="#id7">Progress Notes</a></li><li><a href="#id8">Plan of Treatment</a></li><li><a href="#id9">Visit Diagnoses</a></li><li><a href="#id10">Additional Health Concerns</a></li><li><a href="#id11">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Referral</a></h3><div><ul><li>Humata PCP Referrals-Humana-Radiology (Routine) - Pending Review: <table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td>Radiology</td><td><p>Diagnoses</p><p>Hx of cancer of lung</p><p>History of uterine cancer</p><p>Breast cancer, stage 1, estrogen receptor positive, left (HCC)</p><br/><p>Procedures</p><p>NM PET/CT Skull Base To Thigh</p></td><td><p>[REDACTED], [REDACTED]</p><p>[REDACTED]</p><p>[REDACTED][REDACTED]</p><p>Phone: [REDACTED]</p><p>Fax: [REDACTED]</p></td><td><p/></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>22731265</td><td class="xflagData">Pending Review</td><td><p>Specialty Services Required</p></td><td>[REDACTED]</td><td>[REDACTED]</td><td>2</td><td>2</td></tr></tbody></table><br/><p>Electronically signed by [REDACTED] [REDACTED] PA at [REDACTED]  3:52 PM EDT</p></li></ul></div><h3><a name="id2" href="#toc">Reason for Visit</a></h3><div><ul><li><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Reason</th><th>Comments</th></tr></thead><tbody><tr ID="rfv3"><td ID="reasonrfv3">Follow-up</td><td ID="rfv3comments">Lung nodule</td></tr></tbody></table></li><li>Preauthorization (Routine) - Closed: <table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td>Hematology and Oncology</td><td><p>Procedures</p><p>FOLLOW UP</p></td><td><p>UMHC [REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED] CLINIC</p><p>[REDACTED], [REDACTED] 33176-1936</p></td><td><p>[REDACTED], MD</p><p>[REDACTED][REDACTED]</p><p>[REDACTED][REDACTED][REDACTED]</p><p>Phone: [REDACTED]</p><p>Fax: [REDACTED]</p></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>22722689</td><td class="xflagData">Closed</td><td/><td>[REDACTED]</td><td>[REDACTED]</td><td>1</td><td>1</td></tr></tbody></table><br/></li></ul></div><h3><a name="id3" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col span="3" width="25%"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter5" class="xRowNormal"><td>[REDACTED]  2:40 PM EDT</td><td ID="encounter5type">Office Visit</td><td><p>UHealth Ft. Lauderdale Hematology Oncology</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED][REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><content>Hx of cancer of lung; <br/>History of uterine cancer; <br/>Breast cancer, stage 1, estrogen receptor positive, left (HCC)</content><br/>Discharge Disposition: Home or Self Care - 01</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><table ID="sochist11"><colgroup><col span="2" width="25%"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Former</td><td>Cigarettes</td><td ID="sochist11packsperday">1.5</td><td/><td>Quit: 06/2007</td></tr><tr ID="sochist11smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><colgroup><col span="2" width="25%"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Yes</td><td>5 (1 standard drink = 0.6 oz pure alcohol)</td><td/></tr></tbody></table><table ID="sdohassess2"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>PHQ-2</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess2pair1"><td ID="sdohassess2pair1ques">PHQ-9 Total Score</td><td ID="sdohassess2pair1ans">0</td><td>[REDACTED]</td></tr></tbody></table><table><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex14"><td>Sex Assigned at Birth</td><td ID="BirthSex14Value">Not on file</td><td/></tr><tr ID="GenderIdentity12"><td>Gender Identity</td><td ID="GenderIdentity12Value">Not on file</td><td/></tr><tr ID="SexualOrientation13"><td>Sexual Orientation</td><td ID="SexualOrientation13Value">Not on file</td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id5" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">146</span>/<span class="content_span">81</span></td><td>[REDACTED]  2:41 PM EDT</td><td/></tr><tr ID="pulse_5795260860" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>80</td><td>[REDACTED]  2:41 PM EDT</td><td/></tr><tr ID="temp_5795260860" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>36.7 째C (98 째F)</td><td>[REDACTED]  2:41 PM EDT</td><td/></tr><tr ID="resp_5795260860" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>18</td><td>[REDACTED]  2:41 PM EDT</td><td/></tr><tr ID="SpO2_5795260860" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>96%</td><td>[REDACTED]  2:41 PM EDT</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5795260860" class="xRowNormal"><td class="xcellHeader">Weight</td><td>79.4 kg (175 lb)</td><td>[REDACTED]  2:41 PM EDT</td><td/></tr><tr ID="height_5795260860" class="xRowAlt"><td class="xcellHeader">Height</td><td>157.5 cm (5' 2")</td><td>[REDACTED]  2:41 PM EDT</td><td/></tr><tr ID="bmi_5795260860" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>32.01</td><td>[REDACTED]  2:41 PM EDT</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id6" href="#toc">Patient Instructions</a></h3><div><ul><li>Patient Instructions: <ul><li><p> <span class="xLabel">[REDACTED] - [REDACTED]  2:40 PM EDT</span></p><content><span class="xLabel">Formatting of this note is different from the original.</span><br/><span class="xLabel">Images from the original note were not included.</span><br/><br/><br/>[REDACTED]  <br/><br/>[REDACTED] [REDACTED] [REDACTED] [REDACTED] [REDACTED] [REDACTED] [REDACTED] <br/><br/> <br/><br/> <br/><br/> <br/><br/> 1<br/><br/> 2<br/><br/> 3<br/><br/> <br/>4<br/><br/> 5<br/><br/> 6<br/><br/> 7<br/><br/> 8<br/><br/> 9<br/><br/> 10<br/><br/> <br/>11<br/><br/> 12<br/><br/> 13<br/><br/> 14<br/><br/> 15<br/><br/> 16<br/><br/> 17<br/><br/> <br/>18<br/><br/> 19<br/><br/> 20<br/><br/> 21<br/><br/> 22<br/><br/>FOLLOW UP<br/> 2:40 PM<br/> (20 min.)<br/> [REDACTED], MD<br/> UHealth Ft. Lauderdale Hematology Oncology 23<br/><br/> 24<br/><br/> <br/>25<br/><br/> 26<br/><br/> 27<br/><br/> 28<br/><br/> 29<br/><br/> 30<br/><br/> 31<br/><br/> <br/> <br/><br/> <br/>If you have any questions or concerns regarding your appointment or if you need to reach the office of [REDACTED], please see below:<br/> <br/>[REDACTED]' Contact Information<br/> <br/>Primary Location: <br/>[REDACTED]<br/>Ft. Lauderdale, FL 33308<br/>P-954-776-1800<br/>F-954-318-6551<br/> <br/>TRIAGE NURSE: <br/>[REDACTED] <br/>Or [REDACTED], Option #4<br/>Medical questions<br/>Test Results (imaging/blood work/biopsy results) <br/>Prescription Refills<br/> <br/>ADMINISTRATIVE ASSISTANT: <br/>[REDACTED]<br/>[REDACTED]<br/>General administrative questions for the physician<br/>Work related forms: FMLA, disability<br/><br/>COORDINATION OF CARE:<br/>[REDACTED]<br/>Scheduling follow up appointments<br/><br/>  <br/>If you need to contact your physician, please e-mail them via the MyUHealthChart.com website. <br/> <br/>If you have any questions regarding signing up with MyUHealthChart, please speak with a nurse or send an e-mail to: [REDACTED]. <br/> <br/><br/>Thank you for the opportunity to serve and care for you.  Your opinions are valued. Please respond to our patient survey if you receive one in the mail.<br/> <br/>Scheduling line for Broward: [REDACTED] (Opt#3)<br/> <br/>UHealth Patient and Visitor Services <br/>Phone: [REDACTED] (4357) <br/>Email: [REDACTED] <br/><br/> </content><br/><span class="xLabel">Electronically signed by [REDACTED] at [REDACTED]  2:49 PM EDT</span><br/><br/></li></ul></li></ul>documented in this encounter</div><h3><a name="id7" href="#toc">Progress Notes</a></h3><div><ul><li>[REDACTED], MD - [REDACTED]  2:40 PM EDT: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/><span class="xLabel">Images from the original note were not included.</span><br/><br/><br/>[REDACTED] Comprehensive Cancer Center<br/>Hematology Oncology Progress Note<br/>[REDACTED], MD<br/><br/>  <br/><br/>Patient Name: [REDACTED]<br/>DOB: [REDACTED]<br/>MRN: [REDACTED]<br/>Date of service: [REDACTED]<br/><br/>HISTORY OF PRESENT ILLNESS:<br/><br/>The patient is [REDACTED].  She has been followed since [REDACTED].  He has a history of lung cancer and diagnosis of recurrent uterine cancer.  Details of her condition are as follows:<br/><br/>1.  In regards to her lung cancer this is a tumor resected from the right upper lobe.  It was found as an incidental finding in a chest x-ray while getting evaluated for metastatic disease for her uterine cancer.  She had a wedge resection [REDACTED] under the supervision of [REDACTED].  Pathology showed adenocarcinoma of the right upper lobe nodule, moderately differentiated adenocarcinoma consistent with lung primary, all margins free.  It was a T2 a N0 tumor about 1 cm, focally extending to the visceral pleura and 1 intraparenchymal lymph node negative for tumor.  The tumor was negative for metastatic cancer with prominent pulmonary vein nodule and right paratracheal nodule.  It was negative for ALK and EGFR.  Negative for ROS.  It was completely resected.  The patient received no adjuvant therapy for her lung cancer.<br/><br/>2.  The patient has also uterine cancer diagnosis.  He presented with postmenopausal bleeding.  On [REDACTED], she had diagnostic robotic peritoneal cytology, bilateral retroperitoneal exploration, and bilateral ureteral neurolysis, sentinel lymph node mapping.  The pathology showed endometrial adenocarcinoma FIGO grade 1 cm, stage I cT1 tumor.  She had total hysterectomy, bilateral salpingo-oophorectomy, bilateral pelvic lymphadenectomy, sentinel node sampling, repair of cystocele, laparotomy, and uterosacral ligament vaginal pexy surgery done on [REDACTED]. GYO is [REDACTED].  The patient had radiation treatment x 5 fractions from [REDACTED] to [REDACTED].<br/>During a pelvic examination, [REDACTED], [REDACTED] found a 2 cm exophytic lesion arising from the central apex of the vagina.  Biopsy showed well-differentiated adenocarcinoma compatible with patient's endometrial cancer.  A CAT scan of the chest abdomen and pelvis [REDACTED] showed no evidence of progressive metastatic disease.  There was scarring of the right upper lobe.  Scattered areas of slight bronchiectasis.  No change compared to prior exams.  No acute disease.  No metastatic disease to the spine.  This was a recurrence of endometrial cancer.  The patient had IMRT with [REDACTED] from [REDACTED] to [REDACTED].  The PET scan then done [REDACTED] demonstrated negative PET scan for focal metabolic Active metastatic disease.<br/>The patient then had 5 radiation treatments again with [REDACTED] in [REDACTED] due to minimal recurrence in the vaginal area.  This was completed [REDACTED].<br/><br/>VISIT UPDATE [REDACTED]<br/>Fully vaccinated Covid Pfizer. Completed [REDACTED].<br/>[REDACTED] pet ct Negative for active cancer. (Broward pet imaging)<br/>[REDACTED] labs<br/>Reviewed. B12 normal 587<br/>Folate &gt;24<br/>Vitamin D 53<br/>CEA mildly elevated at 2.6<br/>[REDACTED] Had visit with GYO [REDACTED]<br/>No findings of concern noted. Next visit [REDACTED].<br/><br/>Presently feels well. She is due for colonoscopy, and will be calling GI [REDACTED] [REDACTED] for an appointment.<br/><br/>VISIT UPDATE [REDACTED]<br/><br/>Was diagnosed with ER+ PR+ Her 2 neu negative Left breast cancer by biopsy done in NB in December.<br/>Saw [REDACTED] in January and had in Imp Point left breast lumpectomy and radiation (brachytherapy [REDACTED], completed [REDACTED])<br/>Having right eye cataract surgery in the near future.<br/>Developed infection staph infection from the savi hole. Took antibiotic 10 days last one [REDACTED].<br/><br/>Patient came with spouse. We went over the recent pathology reports.<br/><br/>VISIT UPDATE [REDACTED]<br/>Patient had Pet ct done since last visit. [REDACTED] had ordered it due to her history of uterine cancer. Yearly exam.<br/>This was done at Broward Pet Imaging.<br/>Talked to PA [REDACTED] about the pet ct about [REDACTED] and then patient went for CT chest [REDACTED]. The report of the CT chest pending.<br/>Left message for a verbal report.<br/>Bone density still to be done on [REDACTED].<br/>Taking antibiotics for left breast inflammatory change consistent with cellulitis. Ciprofloxacin duration of 10 days.<br/>Saw [REDACTED] [REDACTED][REDACTED] and follows again with him this [REDACTED][REDACTED].<br/>Of note she is tolerating the letrozole well.<br/><br/>VISIT UPDATE [REDACTED]<br/>Patient went to [REDACTED], thoracic surgery.<br/>Imaging was reviewed by him and radiology service at [REDACTED]<br/>It appears that what she has in the lung is inflammatory.<br/>Having repeat Pet CT next month ( to be scheduled by patient at [REDACTED], [REDACTED]). This order was given to patient by [REDACTED].<br/>Had bone density -as per patient report, had osteopenia but better than last one. Will get that record. From PCP [REDACTED].<br/>Off antibiotics for 2-3 weeks. Seeing Tranakas [REDACTED].<br/><br/>VISIT UPDATE [REDACTED]<br/>-Patient saw [REDACTED] on [REDACTED]; seeing him again on 10/2022<br/>-Taking Letrozole daily <br/>-Patient did PET CT scan in [REDACTED] through her GYO [REDACTED] <br/>-Feeling much better and having more energy<br/><br/>VISIT UPDATE [REDACTED]<br/>-Feeling very well, came with husband.<br/>-Had breast biopsy of left breast lesion [REDACTED] at BHN and it was negative.<br/>-Saw [REDACTED] [REDACTED] and all good.<br/>-Had blood work [REDACTED] and it was sent to labcorp.<br/>-Had pet ct on [REDACTED].<br/><br/>VISIT UPDATE [REDACTED]<br/>- Patient feeling well. Denies chest pains, SOB, or n/v/d<br/>- Saw breast surgeon [REDACTED] late April<br/>- Taking Letrozole 2.5mg every day for breast cancer treatment<br/>- Due to see GYO [REDACTED] in October<br/>- Lab results from [REDACTED] still pending <br/>- Ordered labs to be done for next visit as well.<br/><br/>VISIT UPDATE [REDACTED]<br/>-Pt comes [REDACTED] with concerning news. She states they called her with the results to her PET and noted with growing lung nodule.<br/>-I called and discussed PET with Radiologist, [REDACTED], who read 2024 PET. He agrees with plan for pt to see thoracic surgeon.   <br/>-We discussed labs including cancer markers, CEA, and CA125 being negative. Pt's vitamin D is low, she is not taking it daily, I recommend she start with 1000 units per day. <br/>-I spoke with [REDACTED], thoracic surgeon, about patient he agrees to see her and possibly do biopsy if neccessary. Recommend pt see [REDACTED] as soon as possible, I will print referral. [REDACTED] knows her from prior lung surgery.<br/>-Discussed with pt's PCP, [REDACTED], her new results.<br/>-She continues her Letrozole 2.5mg daily, which continues managing her breast cancer. <br/>-She also follows with [REDACTED] (GYO) closely due to her hx of uterine cancer.<br/><br/>VISIT UPDATE [REDACTED]<br/>-Patient taking Vitamin D 1000 units daily <br/>-Taking Letrozole daily; doing well on it<br/>-Sees GYO [REDACTED] on [REDACTED]; last pap smear was normal<br/>-She is going to be seeing [REDACTED] in Fall 2024; [REDACTED] manages her breast imaging <br/>-Takes BP meds; took her morning BP med [REDACTED] <br/>-Patient saw [REDACTED] CT surgeon on [REDACTED] who reviewed PET CT scan with increasing size of lung nodule; he recommends to repeat a PET CT scan in 3-4 months; based on those results will determine if patient needs a bx of the nodule <br/><br/>VISIT UPDATE [REDACTED]<br/>Saw [REDACTED]--last week. Pet ct -stable.<br/>Having another one [REDACTED].<br/><br/>Had EKG at PCP about [REDACTED] and was fine. No signs of arrhythmias, as per patient report.<br/><br/>No new complaints. Feels well.<br/><br/>VISIT UPDATE [REDACTED]<br/>-Patient was sent back to our office [REDACTED] by PCP [REDACTED], per patient, [REDACTED] is concerned about PET CT scan showing reoccurrence or new cancer<br/>-Lost 2 lbs from last visit <br/>-She had Mohs surgery with dermatologist [REDACTED] on lower lip to remove a skin cancer [REDACTED]<br/>-[REDACTED] called CT surgeon [REDACTED]; she discussed case with him <br/>-Patient is asx; denies chest pain, fever, chills, cough, or shortness of breath <br/>-Gets her MMG/US breasts managed by surgeon [REDACTED]; scheduled for breast imaging in [REDACTED] <br/><br/> <br/><br/>PAST MEDICAL HISTORY:<br/>Past Medical History: <br/>Diagnosis Date <br/> Anxiety 2016 <br/> Bowel disease  <br/> Cataract  <br/> Chickenpox  <br/> History of uterine cancer  <br/> Hx of cancer of lung  <br/> Hx of radiation therapy 10/2016 <br/> Hypertension  <br/> Insomnia 2016 <br/> Macular degeneration 2016 <br/> Measles  <br/> Mumps  <br/> Shingles  <br/> Shortness of breath 2016 <br/><br/>Patient Active Problem List <br/>Diagnosis <br/> Hx of cancer of lung <br/> History of uterine cancer <br/> Breast cancer, stage 1, estrogen receptor positive, left (HCC) <br/><br/>FAMILY HEMATOLOGY-ONCOLOGY HISTORY:<br/>Sister was diagnosed with breast cancer last year [REDACTED].<br/><br/>SOCIAL HISTORY:<br/>Social History <br/><br/>Socioeconomic History <br/> Marital status: Married <br/>  Spouse name: [REDACTED] <br/> Number of children: Not on file <br/> Years of education: Not on file <br/> Highest education level: Not on file <br/>Occupational History <br/> Occupation: RETIRED <br/>Tobacco Use <br/> Smoking status: Former <br/>  Packs/day: 1.5 <br/>  Types: Cigarettes <br/>  Quit date: 06/2007 <br/>  Years since quitting: 17.2 <br/> Smokeless tobacco: Never <br/>Vaping Use <br/> Vaping Use: Never used <br/>Substance and Sexual Activity <br/> Alcohol use: Yes <br/>  Alcohol/week: 5.0 - 7.0 standard drinks of alcohol <br/>  Types: 5 - 7 Glasses of wine per week <br/> Drug use: Never <br/> Sexual activity: Not on file <br/>Other Topics Concern <br/> Not on file <br/>Social History Narrative <br/> Not on file <br/><br/>Social Determinants of Health <br/><br/>Financial Resource Strain: Not on file <br/>Food Insecurity: Not on file <br/>Transportation Needs: Not on file <br/>Physical Activity: Not on file <br/>Stress: Not on file <br/>Social Connections: Not on file <br/>Intimate Partner Violence: Not on file <br/>Housing Stability: Not on file <br/><br/>MEDICATIONS:<br/><br/>Current Outpatient Medications: <br/>  letrozole (FEMARA) 2.5 MG tablet, Take 1 tablet by mouth daily., Disp: 90 tablet, Rfl: 3<br/>  torsemide (DEMADEX) 5 MG tablet, Take 5 mg by mouth daily., Disp: , Rfl: <br/>  verapamil (CALAN-SR) 180 MG CR tablet, 1 tablet., Disp: , Rfl: <br/>  rosuvastatin (CRESTOR) 20 MG tablet, , Disp: , Rfl: <br/>  ALPRAZolam (XANAX) 0.25 MG tablet, Take 0.25 mg by mouth daily as needed. for anxiety, Disp: , Rfl: <br/>  cilostazol (PLETAL) 50 MG tablet, Take  by mouth 2 times daily., Disp: , Rfl: <br/>  metoprolol (TOPROL-XL) 50 MG 24 hr tablet, Take  by mouth daily., Disp: , Rfl: <br/>  potassium chloride SA (KLOR-CON) 20 MEQ tablet, Take  by mouth daily., Disp: , Rfl: <br/>  Multiple Vitamins-Minerals (PreserVision AREDS 2) CAPS, Take  by mouth 2 times daily., Disp: , Rfl: <br/>  Multiple Vitamins-Minerals (CENTRUM ADULTS PO), Take  by mouth., Disp: , Rfl: <br/>  Cholecalciferol (VITAMIN D3 PO), Take 2,000 Units by mouth daily., Disp: , Rfl: <br/>  Ascorbic Acid (VITA-C PO), Take 500 mg by mouth 2 times daily., Disp: , Rfl: <br/><br/>ALLERGIES<br/>Allergies <br/>Allergen Reactions <br/> Lisinopril  <br/><br/>  <br/><br/>REVIEW OF SYSTEMS:<br/><br/>Constitutional: Patient reports 2 lb weight loss. Patient reports no weakness and  fatigue. Patient reports no loss of appetite. Patient reports no night sweats. Patient reports no fever. Patient reports no chills. <br/>Ears, Nose, Mouth, Throat: Patient reports no difficulty swallowing. Patient reports no sore throat. <br/>Cardiac: Patient reports no chest pain. Patient reports no heart palpitations. Patient reports no light headedness. Patient reports no swelling in legs. <br/>Respiratory: Patient reports no cough. Patient reports no sputum production. Patient reports no hemoptysis. Patient reports no shortness of breath. Patient reports no orthopnea. Patient reports no paroxysmal nocturnal dyspnea. <br/>Gastrointestinal: Patient reports no nausea. Patient reports no vomiting. Patient reports no abdominal pain. Patient reports no heartburn. Patient reports no constipation. Patient reports no diarrhea. Patient reports no rectal bleeding. <br/>Skin: Patient reports no skin rash. <br/>Neurological: Patient reports no tingling. Patient reports no weakness of limbs. Patient reports no loss of sensation. <br/>Hematologic/Lymphatic/Immunologic: Patient reports no bruising. Patient reports no bleeding. Patient reports no lumps in arm-pits. Patient reports no lumps in neck. Patient reports no lumps in groin.<br/><br/>  <br/><br/>PHYSICAL EXAM:<br/><br/>General: Well developed, well-nourished in no acute distress. No jaundice or pallor. ECOG 0-1<br/>Ears, Nose, Throat &amp; Neck: Neck is supple. Trachea is midline. <br/>Cardiovascular: Normal S1, S2 , regular.  No murmurs.<br/>Respiratory: Lungs clear to auscultation. Breath sounds symmetric and not diminished .  Adequate air entry bilaterally without rales, Ronchi or wheezes.. <br/>Gastrointestinal: Abdomen is soft, non-tender, non-distended, without masses. <br/>Extremities: No edema. <br/>Neurologic: Patient is alert and oriented X3. No motor deficits present. There are no sensory deficits.<br/><br/>Vitals: <br/> [REDACTED] 1441 <br/>BP: 146/81 <br/>Pulse: 80 <br/>Resp: 18 <br/>Temp: 98 째F (36.7 째C) <br/>TempSrc: Oral <br/>SpO2: 96% <br/>Weight: 175 lb (79.4 kg) <br/>Height: 5' 2" (1.575 m) <br/><br/>  <br/><br/>LABORATORY DATA:<br/>No visits with results [REDACTED] from this visit. <br/>Latest known visit with results is: <br/>Orders Only on [REDACTED] <br/>Component Date Value Ref Range Status <br/> Glucose [REDACTED] 102 (H)  70 - 99 mg/dL Final <br/> BUN [REDACTED] 17  8 - 27 mg/dL Final <br/> Creatinine [REDACTED] 0.84  0.57 - 1.00 mg/dL Final <br/> eGFR [REDACTED] 72  &gt;59 mL/min/1.73 Final <br/> BUN/Creatinine Ratio [REDACTED] 20  12 - 28 Final <br/> Sodium [REDACTED] 144  134 - 144 mmol/L Final <br/> Potassium [REDACTED] 3.7  3.5 - 5.2 mmol/L Final <br/> Chloride [REDACTED] 96  96 - 106 mmol/L Final <br/> CO2 [REDACTED] 32 (H)  20 - 29 mmol/L Final <br/> Calcium, Serum [REDACTED] 10.1  8.7 - 10.3 mg/dL Final <br/> Protein, Total, Serum [REDACTED] 7.0  6.0 - 8.5 g/dL Final <br/> Albumin [REDACTED] 4.5  3.8 - 4.8 g/dL Final <br/> Globulin, Total [REDACTED] 2.5  1.5 - 4.5 g/dL Final <br/> Albumin/Globulin Ratio [REDACTED] 1.8  1.2 - 2.2 Final <br/> [REDACTED], Total [REDACTED] 0.6  0.0 - 1.2 mg/dL Final <br/> Alkaline Phosphatase, S [REDACTED] 101  44 - 121 IU/L Final <br/> AST (SGOT) [REDACTED] 18  0 - 40 IU/L Final <br/> ALT (SGPT) [REDACTED] 22  0 - 32 IU/L Final <br/> CA 15-3 Antigen [REDACTED] 8.7  0.0 - 25.0 U/mL Final <br/> Comment: Roche Diagnostics Electrochemiluminescence Immunoassay (ECLIA)<br/>Values obtained with different assay methods or kits cannot be<br/>used interchangeably.  Results cannot be interpreted as absolute<br/>evidence of the presence or absence of malignant disease.<br/>Performed At: 01<br/>Labcorp [REDACTED]<br/>[REDACTED][REDACTED]/>[REDACTED]<br/>[REDACTED] MD<br/>8008775227<br/> <br/> White Blood Cells, Total [REDACTED] 5.9  3.4 - 10.8 x10E3/uL Final <br/> RBC [REDACTED] 4.49  3.77 - 5.28 x10E6/uL Final <br/> Hemoglobin [REDACTED] 12.9  11.1 - 15.9 g/dL Final <br/> Hematocrit [REDACTED] 40.4  34.0 - 46.6 % Final <br/> MCV [REDACTED] 90  79 - 97 fL Final <br/> MCH [REDACTED] 28.7  26.6 - 33.0 pg Final <br/> MCHC [REDACTED] 31.9  31.5 - 35.7 g/dL Final <br/> RDW [REDACTED] 14.3  11.7 - 15.4 % Final <br/> Platelet Count [REDACTED] 263  150 - 450 x10E3/uL Final <br/> Neutrophils, Percent [REDACTED] 60  Not Estab. % Final <br/> Lymphocytes, Percent [REDACTED] 27  Not Estab. % Final <br/> Monocytes, Percent [REDACTED] 10  Not Estab. % Final <br/> Eosinophils, Percent [REDACTED] 2  Not Estab. % Final <br/> Basophils, Percent [REDACTED] 1  Not Estab. % Final <br/> Neutrophils, Absolute [REDACTED] 3.6  1.4 - 7.0 x10E3/uL Final <br/> Lymphocytes, Absolute [REDACTED] 1.6  0.7 - 3.1 x10E3/uL Final <br/> Monocytes, Absolute [REDACTED] 0.6  0.1 - 0.9 x10E3/uL Final <br/> Eosinophils Absolute [REDACTED] 0.1  0.0 - 0.4 x10E3/uL Final <br/> Basophils, Absolute [REDACTED] 0.1  0.0 - 0.2 x10E3/uL Final <br/> Immature Granulocytes, Percent [REDACTED] 0  Not Estab. % Final <br/> Immature Granulocytes, Absolute [REDACTED] 0.0  0.0 - 0.1 x10E3/uL Final <br/> CEA [REDACTED] 3.5  0.0 - 4.7 ng/mL Final <br/> Comment:                              Nonsmokers          &lt;3.9<br/>                             Smokers             &lt;5.6<br/>Roche Diagnostics Electrochemiluminescence Immunoassay<br/>(ECLIA)<br/>Values obtained with different assay methods or kits<br/>cannot be used interchangeably.  Results cannot be<br/>interpreted as absolute evidence of the presence or<br/>absence of malignant disease.<br/> <br/> CA-125 [REDACTED] 7.9  0.0 - 38.1 U/mL Final <br/> Comment: Roche Diagnostics Electrochemiluminescence Immunoassay (ECLIA)<br/>Values obtained with different assay methods or kits cannot be<br/>used interchangeably.  Results cannot be interpreted as absolute<br/>evidence of the presence or absence of malignant disease.<br/> <br/> Vitamin D, 25-OH, Total [REDACTED] 26.3 (L)  30.0 - 100.0 ng/mL Final <br/> Comment: Vitamin D deficiency has been defined by the Institute of<br/>Medicine and an Endocrine Society practice guideline as a<br/>level of serum 25-OH vitamin D less than 20 ng/mL (1,2).<br/>The Endocrine Society went on to further define vitamin D<br/>insufficiency as a level between 21 and 29 ng/mL (2).<br/>1. IOM (Institute of Medicine). 2010. Dietary reference<br/>   intakes for calcium and D. [REDACTED][REDACTED]: The<br/>   National Academies Press.<br/>2. [REDACTED], [REDACTED] NC, [REDACTED] HA, et al.<br/>   Evaluation, treatment, and prevention of vitamin D<br/>   deficiency: an Endocrine Society clinical practice<br/>   guideline. JCEM. [REDACTED]; 96(7):1911-30.<br/> <br/><br/>PET CT [REDACTED]<br/>Findings:<br/>-Irregular contiguous hypermetabolic changes involving the left breast parenchyma, extending to the cutaneous plane, predominantly upper outer quadrant level, corresponding to contiguous soft tissue granulation/induration components as well as air cavitary elements/surgical field with maximum SUV at 5.5<br/>-Developing hypermetabolic nodal lesion at the upper medial right lung topography, just posterior to the surgical suture line measuring 1.2 cm with maxim SUV at 3.1.<br/>-The remainder of the evaluation demonstrates generally physiologic radiopharmaceutical distrubution throughout.<br/>-Scattered activity at the bowel distribution with excretory-like characteristics.<br/>-No additional discrete focal abnormal hypermetabolic lesions are identified and specifically at the regions of interest, abdomen and pelvis.<br/><br/>Impression:<br/>-Hypermetabolic changes/processes involving the left breast, predominantly upper outer quadrant.<br/>-given the patient's recent surgery/complication as well as radiation therapy favoring .<br/>-A rather extensive multifocal inflammatory or infectious etiology.<br/><br/>-Correlation with patient's clinical presentation advised.<br/>-Developing hypermetabolic nodal lesion at the upper medial right lung, posterior to the surgical suture line, potentially representing early  Or recurrent malignancy/likely related to the right lung primary, although reactive or inflammatory sequela needs to be addressed in the final analysis.<br/>-otherwise, negative evaluation for focal metabolically active recurrent  Nor metastatic gynecological malignancy.<br/>-Management options given the overall parameters to include close follow-up, surveillance pet/ct [REDACTED] to assess the trend of change /evolution. In the meantime, continuous clinical and tumor markers evaluation advised.<br/>Read by radiology [REDACTED].<br/><br/>PET CT Scan [REDACTED]<br/>Persistent irregular multifocal hypermetabolic changes involving the left breast upper outer quadrant, extending to the cutaneous plane, with feature of healing trend of inflammatory etiology, although the observed dominant focal component toward its superior aspect is indeterminate at this point. Otherwise, negative evaluation for new focal hypermetabolic metastatic malignant disease. <br/><br/>PET CT SCAN [REDACTED] <br/>Pet Imaging Institute of [REDACTED][REDACTED] [REDACTED]<br/>There is no definite scintigraphic evidence of high grade hypermetabolic tumor.<br/>Abnormal finding related to the left breast likely reflect the sequela of prior therapy.<br/>Limited comparison to prior outside pelvis that facility did not provide pet images on the included CD.<br/>Lungs: Small patchy area of moderately elevated activity in the left suprahilar upper lobe lung demonstrates SUV max 2.4, measures approximately 2.2 x 1.6 cm (image #70) and appears anatomically similar to the prior examination ([REDACTED]). <br/>Nonspecific consolidation with well-defined margins right suprahilar medial upper lobe lung demonstrates no abnormal uptake .<br/> <br/>[REDACTED] MAM: <br/>No mammographic evidence of malignancy. <br/><br/>[REDACTED] PET CT <br/>IMPRESSION: Slight interval increase in size and metabolic intensity of left suprahilar lung patchy semisolid opacity. This interval slight progression could represent the sequela of either an evolving chronic infectious or inflammatory lesion and or slowly progressive/ well- differentiated neoplasm. Further management should continue to be based upon clinical grounds. <br/>Improved findings related to the left breast likely reflect the evolving sequela. <br/><br/>PET CT Scan [REDACTED]<br/>Since previous PET/CT scan of [REDACTED], metabolically and anatomically stable exam. Persistent hypermetabolic left suprahilar lung patchy semisolid opacity which likely represents a chronic infectious or inflammatory lesion (slightly favored) vs slowly progression/well-differentiated neoplasm. Continued follow up imaging could be of value in a timeframe as desired clinically. Improved findings related to the L breast once again likely reflect the evolving sequela of prior therapy. No new interval evidence of distant hypermetabolic metastatic disease. <br/><br/> <br/><br/>ASSESSMENT:<br/>[REDACTED] is a [REDACTED]. female with<br/><br/>1. History of right lung moderately differentiated adenocarcinoma, s/p RUL lung resection- no active disease. <br/><br/>2. Recurrent endometrial cancer- s/p total hysterectomy, bilateral salpingo-oophorectomy, bilateral pelvic lymphadenectomy, and uterosacral ligament vaginal pexy surgery [REDACTED] with GYO [REDACTED]. She had radiation therapy from 9/2016- 10/2016 and then again in 7/2019- 8/2019. Patient then had 5 radiation treatments again with [REDACTED] in [REDACTED] due to minimal recurrence in the vaginal area. No evidence of active disease per previous PET CT scan on [REDACTED]. Patient follows with [REDACTED] every 6 months and gets a pap smear done. <br/><br/>3. Left breast cancer, T1cN0Mx- s/p left breast lumpectomy and brachytherapy with [REDACTED], completed [REDACTED]. On [REDACTED]. Follows with breast surgeon [REDACTED] who manages her breast imaging. Last MMG and US breasts 11/2023 were stable. <br/><br/>4. Vitamin D deficiency- taking Vitamin D supplementation. <br/><br/>5. Left suprahilar upper lobe opacity per PET CT scan- has decreased uptake on most recent PET CT scan from 5/2024. Favored to be chronic inflammatory lesion but could be a slowly progressive neoplasm. [REDACTED] called [REDACTED] who recommends to monitor and repeat PET CT scan at the end of [REDACTED] (6 months from last PET CT scan). <br/><br/>Orders Placed This Encounter <br/>Procedures <br/> NM PET/CT Skull Base To Thigh <br/><br/>  <br/><br/>PLAN: <br/>1. Rx for PET CT scan to do at the end of [REDACTED]<br/>2. Patient scheduled for OV with [REDACTED] on [REDACTED] and lab appt [REDACTED]<br/><br/>[REDACTED], PA-C<br/><br/>I, [REDACTED], MD,  saw and examined [REDACTED] with PA [REDACTED].<br/>Agree with present evaluation and plan.<br/>Patient continues to be monitored closely in regards the pet ct findings.<br/>I believe we answered her questions to her satisfaction.<br/><br/>[REDACTED], MD<br/>Hematology Oncology<br/>[REDACTED] 5:21 PM<br/><br/></content><br/><span class="xLabel">Electronically signed by [REDACTED], MD at [REDACTED]  5:22 PM EDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id8" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Upcoming Encounters</span><colgroup><col width="10%"/><col width="15%"/><col span="3" width="25%"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter34" class="xRowNormal"><td>[REDACTED] 11:00 AM EST</td><td ID="encounter34type">Appointment</td><td><p>UHealth Ft. Lauderdale Lab</p><p>[REDACTED]</p><p>STE 5</p><p>[REDACTED], FL 33308</p><p>[REDACTED]</p></td><td/><td>Discharge Disposition: Home or Self Care - 01</td></tr><tr ID="encounter33" class="xRowAlt"><td>[REDACTED]  9:40 AM EST</td><td ID="encounter33type">Office Visit</td><td><p>UHealth Ft. Lauderdale Hematology Oncology</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED][REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>Discharge Disposition: Home or Self Care - 01</td></tr></tbody></table><table><span style="font-weight:bold; ">Scheduled Orders</span><colgroup><col width="25%"/><col width="15%"/><col width="10%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Name</th><th>Type</th><th>Priority</th><th>Associated Diagnoses</th><th>Order Schedule</th></tr></thead><tbody><tr ID="procedure36"><td><span class="content_span">NM PET/CT Skull Base To Thigh</span></td><td>Imaging</td><td>Routine</td><td><p>Hx of cancer of lung</p><p>History of uterine cancer</p><p>Breast cancer, stage 1, estrogen receptor positive, left (HCC)</p></td><td ID="procedure36schedule">Expected: [REDACTED] (Approximate), Expires: [REDACTED]</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id9" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx6" class="xRowNormal"><td><p><span class="content_span">Hx of cancer of lung</span></p><p>Personal history of malignant neoplasm of bronchus and lung</p></td></tr><tr ID="vdx7" class="xRowAlt"><td><p><span class="content_span">History of uterine cancer</span></p><p>Personal history of malignant neoplasm of other parts of uterus</p></td></tr><tr ID="vdx8" class="xRowNormal"><td><p><span class="content_span">Breast cancer, stage 1, estrogen receptor positive, left (HCC)</span></p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id10" href="#toc">Additional Health Concerns</a></h3><div><table><colgroup><col span="2" width="50%"/></colgroup><thead><tr><th>Assessment</th><th>Noted Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="assessment1">PHQ-9 Depression Total Score: 0</td><td>[REDACTED]  2:46 PM EDT</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id11" href="#toc">Care Teams</a></h3><div><table ID="ct46"><colgroup><col span="3" width="25%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>[REDACTED], DO</p><p>NPI: [REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>PCP - General</td><td>Internal Medicine</td><td>[REDACTED]</td><td/></tr></tbody></table>documented as of this encounter</div><br/><br/>
</body></html>